Bono P - Search Results

1

C-reactive protein and immune-related adverse events as prognostic biomarkers in immune checkpoint inhibitor treated metastatic renal cell carcinoma patients.

Kankkunen E, Penttilä P, Peltola K, Bono P. Kankkunen E, et al. Among authors: bono p. Acta Oncol. 2022 Oct;61(10):1240-1247. doi: 10.1080/0284186X.2022.2104132. Epub 2022 Jul 29. Acta Oncol. 2022. PMID: 35905053

2

Hypertension as predictor of sunitinib treatment outcome in metastatic renal cell carcinoma.

Bono P, Rautiola J, Utriainen T, Joensuu H. Bono P, et al. Acta Oncol. 2011 May;50(4):569-73. doi: 10.3109/0284186X.2010.543696. Epub 2011 Jan 5. Acta Oncol. 2011. PMID: 21208033

3

Pazopanib after sunitinib failure in patients with metastatic renal cell carcinoma.

Rautiola J, Utriainen T, Peltola K, Joensuu H, Bono P. Rautiola J, et al. Among authors: bono p. Acta Oncol. 2014 Jan;53(1):113-8. doi: 10.3109/0284186X.2013.794957. Epub 2013 May 30. Acta Oncol. 2014. PMID: 23721300 Clinical Trial.

4

Outcome of patients with HER2-positive breast cancer treated with or without adjuvant trastuzumab in the Finland Capecitabine Trial (FinXX).

Joensuu H, Kellokumpu-Lehtinen PL, Huovinen R, Jukkola-Vuorinen A, Tanner M, Kokko R, Ahlgren J, Auvinen P, Saarni O, Helle L, Villman K, Nyandoto P, Nilsson G, Leinonen M, Kataja V, Bono P, Lindman H. Joensuu H, et al. Among authors: bono p. Acta Oncol. 2014 Feb;53(2):186-94. doi: 10.3109/0284186X.2013.820840. Epub 2013 Aug 19. Acta Oncol. 2014. PMID: 23957715 Free PMC article. Clinical Trial.

5

Sunitinib-induced hypertension, neutropaenia and thrombocytopaenia as predictors of good prognosis in patients with metastatic renal cell carcinoma.

Rautiola J, Donskov F, Peltola K, Joensuu H, Bono P. Rautiola J, et al. Among authors: bono p. BJU Int. 2016 Jan;117(1):110-7. doi: 10.1111/bju.12940. Epub 2015 Jun 2. BJU Int. 2016. PMID: 25252180

6

Angiotensin Inhibitors as Treatment of Sunitinib/Pazopanib-induced Hypertension in Metastatic Renal Cell Carcinoma.

Penttilä P, Rautiola J, Poussa T, Peltola K, Bono P. Penttilä P, et al. Among authors: bono p. Clin Genitourin Cancer. 2017 Jun;15(3):384-390.e3. doi: 10.1016/j.clgc.2016.12.016. Epub 2016 Dec 22. Clin Genitourin Cancer. 2017. PMID: 28089721

7

Correlation of c-Met Expression and Outcome in Patients With Renal Cell Carcinoma Treated With Sunitinib.

Peltola KJ, Penttilä P, Rautiola J, Joensuu H, Hänninen E, Ristimäki A, Bono P. Peltola KJ, et al. Among authors: bono p. Clin Genitourin Cancer. 2017 Aug;15(4):487-494. doi: 10.1016/j.clgc.2017.01.021. Epub 2017 Feb 1. Clin Genitourin Cancer. 2017. PMID: 28237182

8

Everolimus-induced pneumonitis associates with favourable outcome in patients with metastatic renal cell carcinoma.

Penttilä P, Donskov F, Rautiola J, Peltola K, Laukka M, Bono P. Penttilä P, et al. Among authors: bono p. Eur J Cancer. 2017 Aug;81:9-16. doi: 10.1016/j.ejca.2017.05.004. Epub 2017 Jun 3. Eur J Cancer. 2017. PMID: 28586749

9

Cancer costs and outcomes in the Finnish population 2004-2014.

Torkki P, Leskelä RL, Linna M, Mäklin S, Mecklin JP, Bono P, Kataja V, Karjalainen S. Torkki P, et al. Among authors: bono p. Acta Oncol. 2018 Feb;57(2):297-303. doi: 10.1080/0284186X.2017.1343495. Epub 2017 Jul 11. Acta Oncol. 2018. PMID: 28696797

10

Cancer costs and outcomes for common cancer sites in the Finnish population between 2009-2014.

Torkki P, Leskelä RL, Linna M, Mäklin S, Mecklin JP, Bono P, Kataja V, Karjalainen S. Torkki P, et al. Among authors: bono p. Acta Oncol. 2018 Jul;57(7):983-988. doi: 10.1080/0284186X.2018.1438656. Epub 2018 Feb 16. Acta Oncol. 2018. PMID: 29451406

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters